Berberine and Cholesterol

What the pooled evidence shows

Two meta-analyses of randomized controlled trials examined berberine's effect on blood lipids. In one analysis of 46 trials in adults with type 2 diabetes, berberine taken alone or alongside standard therapy was associated with reductions in total cholesterol and LDL cholesterol relative to control groups. An earlier meta-analysis of 27 trials in people with diabetes, hyperlipidemia, or hypertension similarly found that adding berberine to lifestyle measures or to lipid-lowering drugs was associated with lower total cholesterol and LDL cholesterol.^{[1], [2]}

Both analyses also reported reductions in triglycerides with berberine compared with control, and increases in HDL cholesterol. In one head-to-head comparison, berberine and conventional lipid-lowering drugs did not differ significantly for total and LDL cholesterol, while berberine appeared more favorable for triglycerides.^{[1], [2]}

Doses studied

Across the pooled trials, berberine was generally given by mouth in divided doses, commonly around 500 mg two to three times daily, corresponding to roughly 1000 to 1500 mg per day. The lipid associations described here reflect that range and the populations studied, mainly adults with type 2 diabetes or elevated blood lipids.^{[1], [2]}

Limitations of the evidence

The authors of these meta-analyses noted that many of the included randomized trials were of limited methodological quality, which constrains how strongly the lipid findings can be interpreted. Much of the data comes from adults with type 2 diabetes or hyperlipidemia, so the results may not extend to other groups. These observations describe averaged trial results and are not medical advice; decisions about managing cholesterol should involve a qualified health professional.^{[1], [2]}